Código QR (código de barras bidimensional)

Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data

Daridorexant (dari), as the first dual orexin receptor antagonist (DORA) marketed in Europe, offers a novel therapeutic approach to insomnia. However, data regarding its real-world safety are scarce. Thus, this study was aimed at assessing its safety profile using a large-scale pharmacovigilance dat...

Fuld beskrivelse

Na minha lista:
Principais autores: Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2024-03-01
Serier:Pharmaceuticals
Fag:
daridorexant
insomnia
orexin
pharmacovigilance databases
Online adgang:https://www.mdpi.com/1424-8247/17/3/342
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker